|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 642396-642420 of 2348685 (93948 Page(s) Totally)
<< < 25691 25692 25693 25694 25695 25696 25697 25698 25699 25700 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-10-18T06:51:39Z |
Oral verrucous hyperplasia: Histologic classification,prognosis, and clinical implications
|
Wang Y.-P.; HSIN-MING CHEN; Kuo R.-C.; Yu C.-H.; Sun A.; Liu B.-Y.; Kuo Y.-S.; Chiang C.-P. |
| 國立成功大學 |
2008-07 |
Oral-facial-digital syndrome with vaginal atresia, hydronephrosis and congenital cardiac defect
|
Su, Wei-Ren; Wang, Ping-Hui; Lian, Jenn-Dong; Lin, Mark Chii-Jeng |
| 國家衛生研究院 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
AC, Tsai;CY, Wang;JP, Liou;HC, Pai;CJ, Hsiao;JY, Chang;JC, Wang;CM, Teng;SL, Pan |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL. |
| 國立成功大學 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L |
| 國立臺灣大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L; 鄧哲明 |
| 臺北醫學大學 |
1997 |
Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet.
|
趙振瑞; Donovan SM; Chao JC-J; Zijlstra RT; and Odle J |
| 實踐大學 |
2011 |
Orally administered mycelial culture of Phellinus linteus exhibits antitumor effects in hepatoma cell-bearing mice
|
Huang, H.Y.;Chieh, S.Y.;Tso, T.K.;Chien, T.Y.;Lin, H.T.;Tsai, Y.C. |
| 亞洲大學 |
2019-08 |
Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy
|
Chen, T.-S.;Chen, T.-S.;Lai, C.-H.;Lai, C.-H.;Shen, C.-Y.;Shen, C.-Y.;Pai, P.-Y.;Pai, P.-Y.;Chen, R.-J.;Chen, R.-J.;PadmaVisw, V.;PadmaViswanadha, V.;Yang, C.-K.;Yang, C.-K.;Chen, M.-C.;Chen, M.-C.;Lin, Y.-M.;Lin, Y.-M.;黃志揚;Huang, Chih-Yang |
| 國家衛生研究院 |
2025-02-27 |
Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid
|
Niu, GH;Hsiao, WC;Lee, PH;Zheng, LG;Yang, YS;Huang, WC;Hsieh, CC;Chiu, TY;Wang, JY;Chen, CP;Huang, CL;You, MS;Kuo, YP;Wang, CM;Wen, ZH;Yu, GY;Chen, CT;Chi, YH;Tung, CW;Hsu, SC;Yeh, TK;Sung, PJ;Zhang, MZM;Tsou, LK |
| 國家衛生研究院 |
2024-05 |
Orally ingested self-powered stimulators for targeted gut-brain axis electrostimulation to treat obesity and metabolic disorders
|
Mac, CH;Tai, HM;Huang, SM;Peng, HH;Sharma, AK;Nguyen, GLT;Chang, PJ;Wang, JT;Chang, Y;Lin, YJ;Sung, HW |
| 國立交通大學 |
2014-12-08T15:16:03Z |
Orange and red organic light-emitting devices employing neutral Ru(II) emitters: Rational design and prospects for color tuning
|
Tung, Yung-Liang; Chen, Li-Shiuan; Chi, Yun; Chou, Pi-Tai; Cheng, Yi-Ming; li, Ese Y. Li; Lee, Gene-Hsiang; Shu, Ching-Fong; Wu, Tang-Iy; Carty, Arthur J. |
| 國立臺灣大學 |
2006 |
Orange and Red Organic Light-Emitting Devices Employing Neutral Ru(II) Emitters: Rational Design and Prospects for Color Tuning
|
Tung, Y.-L.; Chen, L.-S.; Chi, Y.; Chou, P.-T.; Cheng, Y.-M.; Li, E. Y.; Lee, G.-H.; Shu, C.-F.; Wu, F.-I.; Carty, A. J. |
| 國立臺灣大學 |
2006-08 |
Orange and red organic light-emitting devices employing neutral Ru(II) emitters: Rational design and prospects for color tuning
|
Tung, YL; Chen, LS; Chi, Y; Chou, PT; Cheng, YM; Li, EY; Lee, GH; Shu, CF; Wu, TI; Carty, AJ |
| 臺大學術典藏 |
2018-09-10T05:56:01Z |
Orange and red organic light-emitting devices employing neutral Ru(II) emitters: Rational design and prospects for color tuning
|
Tung, Y.-L.;Chen, L.-S.;Chi, Y.;Chou, P.-T.;Cheng, Y.-M.;Li, E.Y.;Lee, G.-H.;Shu, C.-F.;Wu, F.-I.;Carty, A.J.; Tung, Y.-L.; Chen, L.-S.; Chi, Y.; Chou, P.-T.; Cheng, Y.-M.; Li, E.Y.; Lee, G.-H.; Shu, C.-F.; Wu, F.-I.; Carty, A.J.; PI-TAI CHOU |
| 嘉南藥理大學 |
2011 |
Orange Polymethoxylated Flavones Suppress scavenger Receptor Expression in THP-1 Cells and Alter Lipid homeostasis in HepG2 Liver Cells
|
Jui-Hung Yen (顏瑞鴻); Ching-Yi Weng (翁菁憶); Shiming Li; Ya-Hsuan Lo (駱雅萱); Ming-Hsiung Pan (潘敏雄); Shih-Hang Fu (傅士航); Chi-Tang Ho (何其儻); Ming-Jiuan Wu (吳明娟) |
| 國立政治大學 |
2009 |
Orange 手機維修公司之經營計畫
|
連啟祥; Tony Lien |
| 臺大學術典藏 |
2018-09-10T05:58:02Z |
Orange–Red Light-Emitting Diodes Based on a Prestrained InGaN–GaN Quantum-Well Epitaxy Structure
|
Horng-Shyang Chen; Chih-Feng Lu; Dong-Ming Yeh; Chi-Feng Huang; Jian-Jang Huang; Chih-Chung Yang; JIAN-JANG HUANG; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2006 |
Orange{\\&}ndash$\\mathsemicolon$Red Light-Emitting Diodes Based on a Prestrained {InGaN}{\\&}ndash$\\mathsemicolon${GaN} Quantum-Well Epitaxy Structure
|
Horng-Shyang Chen; Chih-Feng Lu; Dong-Ming Yeh; Chi-Feng Huang; Jian-Jang Huang; Chih-Chung Yang; JIAN-JANG HUANG; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2006 |
Orange–Red Light-Emitting Diodes Based on a Prestrained InGaN–GaN Quantum-Well Epitaxy Structure
|
Chen, Horng-Shyang; Lu, Chih-Feng; Yeh, Dong-Ming; Huang, Chi-Feng; Huang, Jian-Jang; Yang, Chih-Chung; Chen, Horng-Shyang; Lu, Chih-Feng; Yeh, Dong-Ming; Huang, Chi-Feng; Huang, Jian-Jang; Yang, Chih-Chung |
| 國立臺灣大學 |
2006 |
Orange–Red Light-Emitting Diodes Based on a Prestrained InGaN–GaN Quantum-Well Epitaxy Structure
|
Chen, Horng-Shyang; Lu, Chih-Feng; Yeh, Dong-Ming; Huang, Chi-Feng; Huang, Jian-Jang; Yang, Chih-Chung |
| 臺大學術典藏 |
2018-09-10T18:04:58Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, M.;Cheng, A.-L.;Park, J.-W.;Park, J.H.;Liang, P.-C.;Hidaka, H.;Izumi, N.;Heo, J.;Lee, Y.J.;Sheen, I.-S.;Chiu, C.-F.;Arioka, H.;Morita, S.;Arai, Y.; PO-CHIN LIANG; ANN-LII CHENG |
| 臺大學術典藏 |
2020-08-11T08:36:43Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.;Cheng A.-L.;Park J.-W.;Park J.H.;Po-Chin Liang;Hidaka H.;Izumi N.;Heo J.;Lee Y.J.;Sheen I.-S.;Chiu C.-F.;Arioka H.;Morita S.;Arai Y.; Kudo M.; Cheng A.-L.; Park J.-W.; Park J.H.; PO-CHIN LIANG; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
| 臺大學術典藏 |
2021-08-31T06:29:32Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.; ANN-LII CHENG; Park J.-W.; Park J.H.; Liang P.-C.; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
Showing items 642396-642420 of 2348685 (93948 Page(s) Totally)
<< < 25691 25692 25693 25694 25695 25696 25697 25698 25699 25700 > >>
View [10|25|50] records per page
|
